Avemar has been recognised and studied worldwide since 1998. As in vitro, in vivo and clinical studies provided further evidence of its safety and effectiveness in the supplementation of oncological treatments, Avemar was registered as “dietary food for special medical purposes for cancer patients” in 2002. Since the discovery of Avemar pulvis, the active ingredient of Avemar, over 13 years of scientific study has been conducted to support its safety and effectiveness, including in vitro, in vivo and human clinical research. Most of the prestigious publications are also published at the PubMed database.
To read more about Avemar and the Avemar Research Program please visit the official research website at: http://research.avemar.com
In scientific studies Avemar:
The information on this website is provided for informational purposes only and is not meant to diagnose or treat any health problem or disease or be a substitute for advice provided by a doctor or other qualified health care professional. Patients should always consult with a doctor or other health care professionals for medical advice or information about a diagnosis and/or treatment. In the case of diagnosis or treatment of any disease, particularly tumour related diseases, a health care professional should always be consulted. Do not attempt to self-treat.